QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Cytori Therapeutics Inc. (CYTX) Granted a Japanese Patent for Its Celution System Technology 0 comments
    Feb 25, 2011 1:49 PM | about stocks: CYTX

    Cytori Therapeutics Inc. is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The company’s Celution System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets, but is not yet available in the US.

    The company announced today that it has been issued Patent No. 4653952 from the Japan Patent Office covering devices for extracting and concentrating the stem and regenerative cells which naturally exist within adipose tissue. Specifically, the patent covers the underlying technology for Cytori’s Celution System family of devices, including the Celution 800 series and the next-generation Celution One series of devices, as well as the StemSource laboratory equipment.

    This patent is the company’s first to be issued in Japan and will serve as Cytori’s foundational patent. Cytori already has ongoing strategic and commercial interests as it formed a joint venture with Olympus Corporation in 2005. Importantly for Cytori, the patent creates a significant barrier to entry for competitors through at least 2022 in the world’s second largest medical market.

    Cytori now has 30 issued patents worldwide. These include 11 issued patents in the United States as well as issued patents in China, Singapore and South Korea. In addition, the company has more than 100 pending patent applications worldwide. For further information about Cytori Therapeutics, please visit the company’s website at cytori.com

    Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net

    Stocks: CYTX
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.